Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 9

Zeitschriftenartikel

Schrodi, S.; Braun, M.; Andrulat, A.; Harbeck, N.; Mahner, S.; Kiechle, M.; Klein, E.; Schnelzer, A.; Schindlbeck, C.; Bauerfeind, I.; Schubert-Fritschle, Gabriele; Nekljudova, V.; Mayr, D.; Weichert, W.; Denkert, C.; Loibl, S. und Engel, J. (2021): Outcome of breast cancer patients with low hormone receptor positivity. Analysis of a 15-year population-based cohort. In: Annals of Oncology, Bd. 32, Nr. 11: S. 1410-1424 [PDF, 1MB]

Wuerstlein, R.; Kates, R.; Gluz, O.; Grischke, E. M.; Schem, C.; Thill, M.; Hasmüller, S.; Köhler, A.; Otremba, B.; Griesinger, F.; Schindlbeck, C.; Trojan, A.; Otto, F.; Knauer, M.; Pusch, R. und Harbeck, N. (2019): Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study. In: Breast Cancer Research and Treatment, Bd. 175, Nr. 2: S. 389-399

Würstlein, R.; Gluz, O.; Kates, R.; Persoon, M.; Wasmayr, M.; Knauer, M.; Koplmüller, R.; Grischke, E.-M.; Schem, C.; Thill, M.; Hasmüller, S.; Griesinger, F.; Köhler, A.; Otremba, B.; Schindlbeck, C.; Reimer, T.; Krauter, J.; Tome, O.; Otto, F.; Friedrichs, K.; Albert, U.-S.; Gebauer, G.; Nitz, U. und Harbeck, N. (2017): Results of multigene assay (MammaPrint (R)) and molecular subtyping (BluePrint (R)) substantially impact treatment decision making in early breast cancer: Final analysis of the WSG PRIME decision impact study. In: Cancer Research, Bd. 77

Tzschaschel, M. L. J.; Rack, B.; Andergassen, U.; Friedl, T. W. P.; Schneeweiss, A.; Müller, V.; Tanja, F.; Pantel, K.; Gade, J.; Lorenz, R.; Rezai, M.; Tesch, H.; Soeling, U.; Polasik, A.; Alunni-Fabbroni, M.; Trapp, E. K.; Mahner, S.; Schindlbeck, C.; Lichtenegger, W.; Beckmann, M. W.; Fasching, P. A. und Janni, W. (2017): Dynamics of circulating tumor cells during the course of chemotherapy and prognostic relevance across molecular subtypes in high-risk early breast cancer patients Results from the adjuvant SUCCESS A trial. In: Cancer Research, Bd. 77

Wuerstlein, R.; Sotlar, K.; Gluz, O.; Hofmann, D.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Morel, P.; Cowens, W.; Hornberger, J.; Kates, R. E.; Pelz, E. und Harbeck, N. (2016): Prosigna®(R) results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study. In: Cancer Research, Bd. 76

Schindlbeck, C.; Andergassen, U.; Jückstock, J.; Rack, B.; Janni, W. und Jeschke, U. (2016): Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets. In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 9: S. 1883-1895

Wuerstlein, R.; Sotlar, K.; Gluz, O.; Hofmann, D.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Morel, P.; Cowens, W.; Hornberger, A.; Kates, R. E.; Pelz, E. und Harbeck, N. (2016): Prosigna® results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study. In: Oncology Research and Treatment, Bd. 39: S. 49

Wuerstlein, R.; Sotlar, K.; Gluz, O.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Ghali, N.; Orujov, E.; Kates, R. E.; Cowens, W.; Hornberger, J.; Pelz, E. und Harbeck, N. (2016): The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer. In: Current Medical Research and Opinion, Bd. 32, Nr. 7: S. 1217-1224

Schindlbeck, C.; Kampik, T.; Janni, W.; Rack, B.; Jeschke, U.; Krajewski, S.; Sommer, H. und Friese, K. (2005): Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas. In: Breast Cancer Research 7 [PDF, 228kB]

Diese Liste wurde am Sun Mar 17 00:25:50 2024 CET erstellt.